These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19660679)

  • 41. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
    Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
    Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
    Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
    Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
    Frosina G
    Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Translating biology into clinic: the case of glioblastoma.
    Lino M; Merlo A
    Curr Opin Cell Biol; 2009 Apr; 21(2):311-6. PubMed ID: 19217766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy for malignant gliomas.
    Kreisl TN
    Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
    J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age dependent and cellular origin (stem versus progenitor) of a selected group of spontaneous brain tumors in humans.
    Jabbour MN; Matioli GT
    Med Hypotheses; 2006; 67(6):1437-42. PubMed ID: 16824702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Congenital glioblastoma.
    Milano GM; Cerri C; Ferruzzi V; Capolsini I; Mastrodicasa E; Genitori L; Aversa F
    Pediatr Blood Cancer; 2009 Jul; 53(1):124-6. PubMed ID: 19309717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
    Addeo R; De Santi MS; Del Prete S; Caraglia M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):863-6. PubMed ID: 19639315
    [No Abstract]   [Full Text] [Related]  

  • 52. Biologic principles of immunotherapy for malignant gliomas.
    Han SJ; Kaur G; Yang I; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):1-16. PubMed ID: 19944962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beyond grade: molecular pathology of malignant gliomas.
    Sulman EP; Guerrero M; Aldape K
    Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment modalities for leptomeningeal metastases.
    Shapiro WR; Johanson CE; Boogerd W
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glioblastoma multiforme: relationship to subventricular zone and recurrence.
    Kimura M; Lee Y; Miller R; Castillo M
    Neuroradiol J; 2013 Oct; 26(5):542-7. PubMed ID: 24199814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
    Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment
    Yang J; Shi Z; Liu R; Wu Y; Zhang X
    Theranostics; 2020; 10(7):3223-3239. PubMed ID: 32194864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence.
    Liu JM; Mao BY; Hong S; Liu YH; Wang XJ
    Adv Ther; 2008 May; 25(5):389-98. PubMed ID: 18463803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.
    Katsetos CD; Dráberová E; Legido A; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):514-20. PubMed ID: 19650077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.